VGL101
Product Specifications
Target
Others, Apoptosis
Related Pathways
Apoptosis, Others
Bioactivity
VGL101 is a human IgG1 monoclonal antibody (mAb) that targets TREM-2. It acts as a pSYK agonist with an EC50 of 0.77 nM. Under ALSP pathological conditions, VGL101 enhances the survival of microglia and monocyte-derived macrophages, inhibits apoptosis, and aids in restoring cell morphology to resemble the normal activated CSF1R state. It is applicable in leukoencephalopathy research. Recommended isotype control: Human IgG1 kappa, Isotype Control.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6319907 1.0 µg DNA
Mboat2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
A129141 100 µL
Anti-Human/PDPN/Podoplanin (SAA0351) (Mouse, Monoclonal, IgG2a, kappa)
Sign In for Pricing
View Details